Does DIGOXIN Cause Basal cell carcinoma? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Basal cell carcinoma have been filed in association with DIGOXIN (Digoxin). This represents 0.2% of all adverse event reports for DIGOXIN.
14
Reports of Basal cell carcinoma with DIGOXIN
0.2%
of all DIGOXIN reports
0
Deaths
12
Hospitalizations
How Dangerous Is Basal cell carcinoma From DIGOXIN?
Of the 14 reports, 12 (85.7%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DIGOXIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does DIGOXIN Cause?
Toxicity to various agents (1,371)
Bradycardia (896)
Dyspnoea (762)
Nausea (762)
Vomiting (715)
Acute kidney injury (708)
Fatigue (638)
Dizziness (616)
Diarrhoea (607)
Drug ineffective (568)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which DIGOXIN Alternatives Have Lower Basal cell carcinoma Risk?
DIGOXIN vs DIHYDRALAZINE
DIGOXIN vs DIHYDROCODEINE
DIGOXIN vs DIHYDROERGOTAMINE
DIGOXIN vs DILANTIN
DIGOXIN vs DILANTIN-125